ALX Oncology Enters $100 Million Loan Facility Agreement wit

ALX Oncology Enters $100 Million Loan Facility Agreement with Oxford Finance and Silicon Valley Bank to Support Ongoing Development of Evorpacept

31.10.2022 - Expects to extend cash runway to mid-2025SOUTH SAN FRANCISCO, Calif., Oct. 31, 2022 (GLOBE NEWSWIRE) - ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO) a clinical-stage immuno-oncology company developing therapies that block the CD47 ... Seite 1

Related Keywords

, Christophera Herr , Kale Frank , Silicon Valley Bank , Senior Managing Director , Valley Bank , Life Science , Silicon Valley ,

© 2025 Vimarsana